fbpx
  • Home
  • Study Details
Open

Pediatric Relapsing Remitting Multiple Sclerosis Study

The purpose of this study is to evaluate a new drug (BIIB017) for the treatment of pediatric patients with Relapsing Remitting Multiple Sclerosis. This drug is already used to treat adults with MS.

Age & Gender

  • 10 years ~ 18 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)

Location

North Carolina (Orange)

What will be asked of you

There are two parts to this study. Everyone participating will be in Part 1, and you may also choose to be in Part 2. For Part 1, you will have one visit to determine if you are eligible, and 11 clinic visits. You will have an MRI at 4 of the 11 clinic visits. You will also have 2 phone calls. If you choose to participate in part 2, you will visit the clinic 8 times, have one follow-up visit, and you may have another MRI.

Incentives

Reimbursement will be provided for travel, meals, and lodging expenses, if needed

In-person visits : 13-21
Phone or online visits : 2
Total length of participation : Up to 4 years

Looking for Specific Volunteers

Able to participate:

  • Have a confirmed diagnosis of relapsing remitting multiple sclerosis
  • Between 10 and less than 18 years old
  • At least one MS episode (relapse) in the last 12 months, or at least 2 MS episodes (relapses) in the last 24 months
  • Able to walk unrestricted or able to walk without aid or rest for at least 100 meters

Not eligible if:

  • Have been diagnosed with progressive MS
  • Have had a recent MS relapse within 30 days prior to the study start
  • Have a history of severe allergic or anaphylactic reactions
  • Have a history of seizure disorder or unexplained blackouts
  • Have a history of suicidal thoughts or severe depression within 3 months prior to the study start

Contact the Team

Visit Location

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Irena Dujmovic Basuroski
Neurology

Study Type

Clinical or Medical
Interventional

Study Topics

Brain, Head, Nervous System
Child and Teen Health
Immune System/Infections

IRB Number

19-0837

ClinicalTrials.gov

NCT03958877

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.